Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Unicycive Therapeutics, Inc. shareholders
As of Jun 30, 2026, 77 institutions reported holding Unicycive Therapeutics, Inc., 46.9% of its shares. Largest: Nantahala Capital Management, LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Unicycive Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2.8M | 10.1% | +1.86M | Aug 19, 2026 |
| BlackRock | 1.41M | 5.1% | +1.38M | Aug 7, 2026 |
| Vanguard | 1.4M | 5.0% | +477K | Aug 13, 2026 |
| Octagon Capital Advisors LP | 1M | 3.6% | no change | Aug 14, 2026 |
| Geode Capital | 564K | 2.0% | +360K | Aug 12, 2026 |
| Vivo Capital, LLC | 550K | 2.0% | −1.24M | Aug 14, 2026 |
| Marshall Wace, LLP | 548K | 2.0% | +393K | Aug 13, 2026 |
| Logos Global Management LP | 474K | 1.7% | no change | Aug 14, 2026 |
| State Street | 450K | 1.6% | +370K | Aug 7, 2026 |
| Diametric Capital, LP | 374K | 1.3% | +294K | Aug 14, 2026 |